Metformin Reduces NGF-Induced Tumour Promoter Effects in Epithelial Ovarian Cancer Cells
Epithelial ovarian cancer (EOC) is a lethal gynaecological neoplasm characterized by rapid growth and angiogenesis. Nerve growth factor (NGF) and its high affinity receptor tropomyosin receptor kinase A (TRKA) contribute to EOC progression by increasing the expression of c-MYC, survivin and vascular...
Saved in:
Main Authors: | Maritza P. Garrido (Author), Renato Salvatierra (Author), Manuel Valenzuela-Valderrama (Author), Christopher Vallejos (Author), Nicole Bruneau (Author), Andrea Hernández (Author), Margarita Vega (Author), Alberto Selman (Author), Andrew F. G. Quest (Author), Carmen Romero (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2020-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mechanisms of Regulation of the Expression of miRNAs and lncRNAs by Metformin in Ovarian Cancer
by: Ignacio Alfaro, et al.
Published: (2023) -
Clinicopathologic characteristics of epithelial ovarian tumours in Ile-Ife, Nigeria
by: AO Anjorin, et al.
Published: (2020) -
Characterization of tumour microenvironment reprogramming reveals invasion in epithelial ovarian carcinoma
by: Yuanfu Zhang, et al.
Published: (2023) -
NGF and therapeutic prospective: what have we learned from the NGF transgenic models?
by: Luigi Aloe, et al.
Published: (2015) -
Tomm34 is commonly expressed in epithelial ovarian cancer and associates with tumour type and high FIGO stage
by: Petr Muller, et al.
Published: (2019)